leon-nanodrugs GmbH, corporate

leon-nanodrugs GmbH,

26.10.2022 - 11:03:26

EQS-News: Harro H?fliger and LEON collaborate to bring the innovative NANOus LNP-encapsulation device to market for rapid, large-scale prophylactic vaccine manufacturing

and follow us on LinkedIn.


leon-nanodrugs? (?LEON?) aim is to create a new norm for the production of nanoparticle-based therapeutics by establishing their technology for seamless scale-up and high-performance output. The Munich-based private company was founded in 2011 and since then has successfully pursued its mission of enabling the biotechnology and pharmaceutical industry, as well as Contract Development and Manufacturing Organizations (CDMOs), with a disruptive manufacturing technology to encapsulate mRNAs or active pharmaceutical ingredients (APIs) into lipid nanoparticles (LNPs). The increase in efficiency and speed will broaden access to mRNA vaccines, therapeutically enhanced biologics or small molecules, and improve economic feasibility for the benefit of patients and healthcare systems. LEON?s intellectual property is broadly protected with international coverage through 2041.

For further information, please visit https://leon-nanodrugs.com/ and follow us on LinkedIn and Twitter.

CONTACT: leon-nanodrugs GmbH Andrea Cusack, CEO Telefon: +49-89-41424889-0 E-Mail: A.Cusack@leon-nanodrugs.com

Harro H?fliger GmbH Thomas Weller, CEO Telefon: +49 7191 501-5113 E-Mail: thomas.weller@hoefliger.deMEDIA INQUIRIES:MC Services AG Katja Arnold / Eva Bauer Telefon: +49-89-210228-0 E-Mail: leon-nanodrugs@mc-services.eu

Harro H?fliger GmbH Rosemarie Christ Telefon: +49 7191 501-1627 E-Mail: rosemarie.christ@hoefliger.de

For high resolution photos, please contact leon-nanodrugs@mc-services.eu

26.10.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com

Language: English Company: leon-nanodrugs GmbH Kopernikusstra?e 9 81679 Munich

Germany E-mail: info@leon-nanodrugs.com Internet: https://leon-nanodrugs.com/ EQS News ID: 1471829 ? End of News EQS News Service


@ dgap.de